Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT

Oncogene

Volumn 27, Issue 57, 2008, Pages 7171-7179

  McKenzie, S ^a   Sakamoto, S ^a   Kyprianou, N ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Angiogenesis; Apoptosis; Hypoxia; Maspin; Prostate cancer; Tumor suppression

Indexed keywords

MASPIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL HYPOXIA; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; EXTRACELLULAR MATRIX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SERPINS; SIGNAL TRANSDUCTION;

EID: 57349153982     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.321     Document Type: Article

References (32)

1. Abraham S, Zhang W, Greenberg N, Zhang M. (2003). Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J Urol 169: 1157-1161.
2. Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Ellis Z, Hendrix MJ. (2005). Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol Ther 4: 400-406.
3. Blacque O, Worrall D. (2002). Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem 277:10783-10788.
4. Cher M, Biliran Jr H, Bhagat S, Meng Y, Che M, Lockett J et al. (2003). Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci USA 100:7847-7852.
5. Corley KM, Taylor CJ, Lilly B. (2005). Hypoxia-inducible factor 1 alpha modulates adhesion, migration and FAK phosphorylation in vascular smooth cells. J Cell Biochem 96:971-985.
6. Denk AE, Bettstetter M, Wild PJ, Hoek K, Bataille F, Dietmaier W et al. (2007). Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res 20: 112-119.
7. Debes JD, Tindall DJ. (2004). Mechanisms of androgen-refractory prostate cancer. New Engl J Med 351:1488-1490.
8. Domann F, Rice J, Hendrix M, Futscher B. (2000). Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85:805-810.
9. Ferrara N, Gerber H, LeCouter J. (2003). The biology of VEGF and its receptors. Nat Med 9:669-676.
10. Fu X, Choi E, Bubley G, Balk S. (2005). Identification of hypoxia inducible factor-1α (HIF-1α) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 63:215-221.
11. Gao N, Shen L, Zhang Z, Leonard SS, He H, Zhang XG et al. (2004). Arsenite induces HIF-1alpha and VEGF through PI3 K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol Cell Biochem 255:33-45.
12. Garrison JB, Shaw Y-J, Chen C-S, Kyprianou N. (2007). Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity. Cancer Res 67:11344-11352.
13. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. (2006). Cancer Statistics, 2006 CA. Cancer J Clin 56:106-130.
14. Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S. (2002). Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21:4089-4098.
15. Kimbro KS, Simons JW. (2006). Hypoxia-inducible factor-1 in human breast and prostate cancer. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 13:739-749.
16. Kyprianou N, Bruckheimer EM, Guo Y. (2000). Cell proliferation and apoptosis in prostate cancer: significan ce in disease progression and therapy. Histol Histopathol 15:1211-1223.
17. Lee BL, Kim WH, Jung J, Cho SJ, Park JW, Kim J et al. (2008). A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer. Carcinogenesis 29:44-451.
18. Lee SM, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG. (2006). Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells. Cancer Lett 242:231-238.
19. Liu J, Yin S, Reddy N, Spencer C, Sheng S. (2004). Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res 64: 1703-1711.
20. McKenzie S, Kyprianou N. (2006). Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J Cell Biochem 97:18-32.
21. Ngamkitidechakul C, Warejcka D, Burke J, O'Brien W, Twinning S. (2003). Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. J Biol Chem 278:31796-31806.
22. Rennebeck G, Martelli M, Kyprianou N. (2005). Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis. Cancer Res 65:11230-11235.
23. Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K. (2005). The tumor bed-effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Res 65:2387-2396.
24. Schaefer J, Zhang M. (2003). Role of maspin in tumor metastasis and angiogenesis. Curr Mol Med 3:653-658.
25. Semenza G. (2002). HIF-1α and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8:62-67.
26. Semenza G. (2003). Targeting HIF-1α for Cancer Therapy. Nat Rev Cancer 3:721-732.
27. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R. (1996). Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93: 11669-11674.
28. Shi YH,Wang YX, Bingle L, Gong LH, HengWJ, Li Y et al. (2005). In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: in volvement of PI-3K/Akt and MEK1/ERK pathways. J Pathol 205:530-536.
29. Tahmatzopoulos T, Sheng S, Kyprianou N. (2005). Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene 24: 5375-5383.
30. Welsh S, Powis G. (2003). Hypoxia inducible growth factors as a cancer drug target. Curr Cancer Drug Targets 3:391-405.
31. Zhang M, Volpert O, Shi Y, Bouck N. (2000). Maspin is an angiogenesis inhibitor. Nat Med 6:196-199.
32. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S et al. (1994). Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526-529.